FindTrial
Sign In

Effect of higher dose of vitamin D supplementation in control of disease activity in SLE

Multi-institutional Network Program on Systemic lupus Erythematosus: Understanding the diversity of SLE - VIDSLE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019658
Enrollment
680
Registered
2019-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M321- Systemic lupus erythematosus withorgan or system involvement

Interventions

Intervention1: vitamin D 60000 units: vitamin D 60000 units weekly for 5 weeks followed by same dose monthly for 12 months Control Intervention1: vitamin D 30,000 IU: Vitamin D 30,000 IU monthly for 1

Sponsors

Department of Biotechnology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: SLE diagnosed on basis of SLICC criteria SLEDAI less or equal to 8

Exclusion criteria

Exclusion criteria: pregnancy, lactation, cancer, hypercalcemia

Design outcomes

Primary

MeasureTime frame
Change in SLEDAI scoreTimepoint: 6 months—

Secondary

MeasureTime frame
Change in anti-dsDNA and IFN-alpha levelTimepoint: 6 and 12 months;Frequency of flareTimepoint: over 12 months—

Countries

India

Contacts

Public ContactAmita Aggarwal

Sanjay Gandhi Postgraduate Institute

aa.amita@gmail.com9473584267

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026